Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

DOXYCYCLINE

DOXYCYCLINE

Standard Dose
EQ 100MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DOXYCYCLINE is listed in Drugs@FDA under application 209582 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DOXYCYCLINE Form and strength TABLET;ORAL - EQ 100MG BASE Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2026-01-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXYCYCLINE is listed in Drugs@FDA under application 209582 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOXYCYCLINE Form and strength TABLET;ORAL - EQ 100MG BASE Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2026-01-17 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.